152 related articles for article (PubMed ID: 79809)
1. A possible role for propranolol in the treatment of renal osteodystrophy.
Caro JF; Besarab A; Burke JF; Glennon JA
Lancet; 1978 Aug; 2(8087):451-4. PubMed ID: 79809
[TBL] [Abstract][Full Text] [Related]
2. Suppression of secondary hyperparathyroidism by propranolol in renal failure patients.
Besarab A; Caro JF; Ihle BU; Burke JF; Glennon JA; Fischer JA
Nephron; 1981; 27(3):127-33. PubMed ID: 7219643
[TBL] [Abstract][Full Text] [Related]
3. A trial of calcitonin therapy in renal osteodystrophy.
Delano BG; Baker R; Gardner B; Wallach S
Nephron; 1973; 11(5):287-93. PubMed ID: 4753519
[No Abstract] [Full Text] [Related]
4. 1,25(OH)2D3 and 25-OHD3 in the treatment of renal osteodystrophy: comparison of combined versus 1,25(OH)2D3 administration alone.
Coen G; Taccone Gallucci M; Bonucci E; Ballanti P; Bianchi AR; Bianchini G; Matteucci MC; Mazzaferro S; Picca S; Taggi F; Cinotti GA; Casciani CU
Miner Electrolyte Metab; 1983; 9(1):19-27. PubMed ID: 6687749
[No Abstract] [Full Text] [Related]
5. 1alpha-Hydroxycholecalciferol in renal osteodystrophy.
Pierides AM; Ellis HA; Ward MK; Simpson W; Kerr DN
Calcif Tissue Res; 1977 May; 22 Suppl():105-11. PubMed ID: 912511
[No Abstract] [Full Text] [Related]
6. Plasma hydroxyproline in renal osteodystrophy.
Varghese Z; Moorhead JF; Tatler GL; Baillod RA; Wills MR
Proc Eur Dial Transplant Assoc; 1973; 10(0):187-96. PubMed ID: 4802560
[No Abstract] [Full Text] [Related]
7. PTH and bone markers of renal osteodystrophy in predialysis chronic renal failure.
Coen G; Mazzaferro S; Ballanti P; Bonucci E
J Endocrinol Invest; 1992; 15(9 Suppl 6):129-33. PubMed ID: 1300330
[No Abstract] [Full Text] [Related]
8. [Correlations between osteodensitometry and parameters of uremic osteodystrophy].
Sforzini S; Viganò MR; Beretta P; Rosa M; d'Amico P; Lomuscio G; Paesani R
Minerva Med; 1985 Mar; 76(9-10):445-8. PubMed ID: 3982703
[No Abstract] [Full Text] [Related]
9. Osteopenia during long-term haemodialysis: response to vitamin D3 analogues.
Muirhead N; Adami S; Fraser RA; Catto GR; Edward N; O'Riordan JL
Proc Eur Dial Transplant Assoc; 1981; 18():567-72. PubMed ID: 6895786
[No Abstract] [Full Text] [Related]
10. Renal osteodystrophy in non-dialysed patients with chronic renal failure.
Andresen J; Nielsen HE
Acta Radiol Diagn (Stockh); 1980; 21(6):803-6. PubMed ID: 7234496
[TBL] [Abstract][Full Text] [Related]
11. Long-term experience of alfacalcidol in renal osteodystrophy.
Sharman VL; Brownjohn AM; Goodwin FJ; Hately W; Manning RM; O'Riordan JH; Papapoulos SE; Marsh FP
Q J Med; 1982; 51(203):271-8. PubMed ID: 7146311
[TBL] [Abstract][Full Text] [Related]
12. Calcium and phosphate metabolism in chronic renal failure, with particular reference to the effect of 1 alpha-hydroxyvitamin D3.
Madsen S
Acta Med Scand Suppl; 1980; 638():3-120. PubMed ID: 6929650
[No Abstract] [Full Text] [Related]
13. Serum parathyroid hormone concentration in chronic renal failure patients on maintenance haemodialysis.
Wills MR; Fairney A; Varghese Z; Tatler GL; Baillod RA; Moorhead JF
Clin Chim Acta; 1974 Nov; 57(1):83-9. PubMed ID: 4430145
[No Abstract] [Full Text] [Related]
14. [Variations in serum levels of phosphorus (iP), calcium (Ca), calcitonin (iCT) and parathormone (iPTH) in patients under periodic hemodialysis. Effects of exogenous calcitonin therapy].
Bucciante G; Bernardi A; Biasia F; Milan G; Donato D
Minerva Med; 1985 Mar; 76(9-10):415-7. PubMed ID: 3982698
[No Abstract] [Full Text] [Related]
15. Hypophosphataemia and osteomalacia in haemodialysis patients not taking phosphate binders.
Ahmed KY; Varghese Z; Meinhard EA; Baillod RA; Skinner RK; Wills MR; Moorhead JF
Adv Exp Med Biol; 1977; 81():581-90. PubMed ID: 899942
[No Abstract] [Full Text] [Related]
16. Osteodystrophy of dialysed patients treated with vitamin D.
Verberckmoes R; Bouillon R; Krempien B
Proc Eur Dial Transplant Assoc; 1973; 10(0):217-26. PubMed ID: 4370246
[No Abstract] [Full Text] [Related]
17. Comparison of 1 alpha-hydroxycholecalciferol and 25-hydroxycholecalciferol in the treatment of renal osteodystrophy: greater effect of 25-hydroxycholecalciferol on bone mineralization.
Fournier A; Bordier P; Gueris J; Sebert JL; Marie P; Ferrière C; Bedrossian J; DeLuca HF
Kidney Int; 1979 Feb; 15(2):196-204. PubMed ID: 513484
[No Abstract] [Full Text] [Related]
18. Renal bone disease in patients on haemodialysis: biochemical and radiological assessment.
Lye WC; Lee EJ
Ann Acad Med Singap; 1992 Nov; 21(6):760-4. PubMed ID: 1295414
[TBL] [Abstract][Full Text] [Related]
19. Renal osteodystrophy in children with end-stage kidney failure.
Chan JC
Va Med; 1979 May; 106(5):384-90. PubMed ID: 463255
[TBL] [Abstract][Full Text] [Related]
20. Propranolol in uraemic osteodystrophy.
Brancaccio D; Galmozzi C; Casati S; Ponticelli C
Lancet; 1978 Oct; 2(8096):940. PubMed ID: 81949
[No Abstract] [Full Text] [Related]
[Next] [New Search]
